Copyright
©The Author(s) 2020.
World J Gastrointest Oncol. Oct 15, 2020; 12(10): 1119-1132
Published online Oct 15, 2020. doi: 10.4251/wjgo.v12.i10.1119
Published online Oct 15, 2020. doi: 10.4251/wjgo.v12.i10.1119
Table 1 Treatments for all patients, n (%)
| Surgical procedure | 2000-2004 (n = 853) | 2005-2009 (n = 1707) | 2010-2014 (n = 3327) | 2000-2014 (n = 5887) |
| Proximal gastrectomy | 60 (7) | 152 (8.9) | 228 (6.9) | 440 (7.5) |
| Subtotal distal gastrectomy | 398 (46.7) | 946 (55.4) | 1646 (49.5) | 2990 (50.8) |
| Total gastrectomy | 189 (22.2) | 354 (20.7) | 771 (23.2) | 1314 (22.3) |
| Palliative surgery | 80 (9.4) | 97 (5.7) | 193 (5.8) | 370 (6.3) |
| Exploratory laparotomy | 23 (2.7) | 45 (2.6) | 200 (6) | 268 (4.6) |
| No surgery | 103 (12.1) | 113 (6.6) | 289 (8.7) | 505 (8.6) |
- Citation: Zhai Z, Zhu ZY, Cong XL, Han BL, Gao JL, Yin X, Zhang Y, Lou SH, Fang TY, Wang YM, Li CF, Yu XF, Ma Y, Xue YW. Changing trends of clinicopathologic features and survival duration after surgery for gastric cancer in Northeast China. World J Gastrointest Oncol 2020; 12(10): 1119-1132
- URL: https://www.wjgnet.com/1948-5204/full/v12/i10/1119.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v12.i10.1119